DRUGMAX COM INC
10QSB, EX-27.1, 2000-11-14
HEALTH SERVICES
Previous: DRUGMAX COM INC, 10QSB, EX-10.11, 2000-11-14
Next: ACCENT COLOR SCIENCES INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the 10-QSB
of DrugMax.com, Inc. for the 6 months ended September 30, 2000 and is qualified
in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-END>                               SEP-30-2000
<CASH>                                       5,475,136
<SECURITIES>                                         0
<RECEIVABLES>                               10,872,282
<ALLOWANCES>                                   472,870
<INVENTORY>                                  9,262,283
<CURRENT-ASSETS>                            29,000,928
<PP&E>                                         852,765
<DEPRECIATION>                                 133,343
<TOTAL-ASSETS>                              54,857,181
<CURRENT-LIABILITIES>                       21,417,815
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         6,419
<OTHER-SE>                                  32,038,589
<TOTAL-LIABILITY-AND-EQUITY>                54,857,181
<SALES>                                     67,862,991
<TOTAL-REVENUES>                            67,862,991
<CGS>                                       65,495,437
<TOTAL-COSTS>                               65,495,437
<OTHER-EXPENSES>                             4,043,382
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             471,611
<INCOME-PRETAX>                            (2,147,439)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,147,439)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,147,439)
<EPS-BASIC>                                     (0.34)
<EPS-DILUTED>                                   (0.34)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission